NCT07546331 Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction
| NCT ID | NCT07546331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Breast Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-02-18 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-02-18 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares measurements of body composition to outcomes of breast reconstruction.
Eligibility Criteria
Inclusion Criteria: 1. Patients must have histologically confirmed breast malignancy or increased risk of developing a breast malignancy. 2. Age ≥ 18 years. 3. Scheduled to undergo mastectomy with immediate breast reconstruction using a permanent implant, tissue expander, or autologous tissue (e.g. Deep Inferior Epigastric Perforator (DIEP) flap, muscle-sparing Transverse Rectus Abdominis Myocutaneous (msTRAM) flap, Profunda Artery Perforator (PAP) flap). 4. Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1. Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study. 2. Pregnant or breastfeeding. 3. Patients assigned male at birth. 4. Non-cisgender women. 5. Patients with implanted electronic medical devices (e.g. pacemaker, defibrillator). 6. Patients with prosthetic limbs.
Contact & Investigator
Merisas Piper, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07546331 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07546331 currently recruiting?
Yes, NCT07546331 is actively recruiting participants. Contact the research team at Michael.Choi@ucsf.edu for enrollment information.
Where is the NCT07546331 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07546331 clinical trial?
NCT07546331 is sponsored by University of California, San Francisco. The principal investigator is Merisas Piper, MD at University of California, San Francisco. The trial plans to enroll 40 participants.